Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ZKAB001 |
Trade Name | |
Synonyms | ZKAB 001|ZKAB-001|Socazolimab|STIA1014|STI-A1014|STI A1014 |
Drug Descriptions |
ZKAB001 is a monoclonal antibody targeting CD274 (PD-L1), which potentially induces antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibition of tumor growth (PMID: 36469563). |
DrugClasses | PD-L1/PD-1 antibody 121 |
CAS Registry Number | 2305043-30-3 |
NCIT ID | C162504 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Etoposide + ZKAB001 | Carboplatin Etoposide ZKAB001 | 0 | 0 |
ZKAB001 | ZKAB001 | 0 | 0 |